The Case for Cognitive-Behavioral Models in the Treatment with Psychedelic States | Panel
Prof. Dr. Matthew Johnson | Johns Hopkins University School of Medicine
https://insight-conference.eu/speaker/matthew-johnson/
Dr. med. Ansgar Rougemont-Bücking | University of Fribourg, Switzerland
https://insight-conference.eu/speaker/ansgar-rougemont-buecking/
Dr. Max Wolff | Science Division of the MIND Foundation
https://insight-conference.eu/speaker/max-wolff/
PhD Ingmar Gorman | Psychedelic Education and Continuing Care Program (Director)
https://insight-conference.eu/speaker/ingmar-gorman/
Cognitive-behavioral therapy and psychedelics? How strange does that sound? The clinical approaches associated with psychedelic therapies have historically been linked to in-depth psychologies and humanistic theories. With the third wave of cognitive-behavioural therapies and the integration of contextual theories and mindfulness methods into this framework, things have changed. More and more clinical teams seem to adapt themselves to this new way of conceptualizing treatments based on the principles of learning psychology.
--------------------
We are a non-profit organisation - but you can support our work with a donation! With your tax-deductible donation we can achieve our goals and visions. Every euro or dollar you donate will fund a project or researcher who is committed to safe and legal therapies, harm reduction and the development of the European health system. Please indicate "CBT model Video" as the intended purpose.
Link: https://mind-foundation.org/donate
----------------------
What are the pros and cons of this new behavioural trend in psychedelic treatments? Why is it necessary to reform the theoretical and therapeutic principles that psychedelic treatments were originally based on? What would be the main challenges coming from the historical practises and how does a modern therapeutic framework respond to these? Last but not least: what is the role of spirituality in these new frameworks and would they be able to deal with both the potential advantages and the disadvantages of spiritual thinking and practices?
This panel is all about clinical innovation and discussing the challenges that come with traditional understanding of psychedelic therapies. It is moderated by Matthew Johnson.
Prof. Dr. Matthew Johnson | Johns Hopkins University School of Medicine
https://insight-conference.eu/speaker/matthew-johnson/
Dr. med. Ansgar Rougemont-Bücking | University of Fribourg, Switzerland
https://insight-conference.eu/speaker/ansgar-rougemont-buecking/
Dr. Max Wolff | Science Division of the MIND Foundation
https://insight-conference.eu/speaker/max-wolff/
PhD Ingmar Gorman | Psychedelic Education and Continuing Care Program (Director)
https://insight-conference.eu/speaker/ingmar-gorman/
Cognitive-behavioral therapy and psychedelics? How strange does that sound? The clinical approaches associated with psychedelic therapies have historically been linked to in-depth psychologies and humanistic theories. With the third wave of cognitive-behavioural therapies and the integration of contextual theories and mindfulness methods into this framework, things have changed. More and more clinical teams seem to adapt themselves to this new way of conceptualizing treatments based on the principles of learning psychology.
——————–
We are a non-profit organisation – but you can support our work with a donation! With your tax-deductible donation we can achieve our goals and visions. Every euro or dollar you donate will fund a project or researcher who is committed to safe and legal therapies, harm reduction and the development of the European health system. Please indicate “CBT model Video” as the intended purpose.
Link: https://mind-foundation.org/donate
———————-
What are the pros and cons of this new behavioural trend in psychedelic treatments? Why is it necessary to reform the theoretical and therapeutic principles that psychedelic treatments were originally based on? What would be the main challenges coming from the historical practises and how does a modern therapeutic framework respond to these? Last but not least: what is the role of spirituality in these new frameworks and would they be able to deal with both the potential advantages and the disadvantages of spiritual thinking and practices?
This panel is all about clinical innovation and discussing the challenges that come with traditional understanding of psychedelic therapies. It is moderated by Matthew Johnson.
){kind=link}
Comments